Cataland S - Search Results

1

Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura.

Peyvandi F, Scully M, Kremer Hovinga JA, Cataland S, Knöbl P, Wu H, Artoni A, Westwood JP, Mansouri Taleghani M, Jilma B, Callewaert F, Ulrichts H, Duby C, Tersago D; TITAN Investigators. Peyvandi F, et al. Among authors: cataland s. N Engl J Med. 2016 Feb 11;374(6):511-22. doi: 10.1056/NEJMoa1505533. N Engl J Med. 2016. PMID: 26863353 Free article. Clinical Trial.

2

Immunotherapy for thrombotic thrombocytopenic purpura.

Cataland SR, Wu HM. Cataland SR, et al. Curr Opin Hematol. 2005 Sep;12(5):359-63. doi: 10.1097/01.moh.0000170534.33517.99. Curr Opin Hematol. 2005. PMID: 16093780 Review.

3

A rapid test for the diagnosis of thrombotic thrombocytopenic purpura using surface enhanced laser desorption/ionization time-of-flight (SELDI-TOF)-mass spectrometry.

Jin M, Cataland S, Bissell M, Wu HM. Jin M, et al. Among authors: cataland s. J Thromb Haemost. 2006 Feb;4(2):333-8. doi: 10.1111/j.1538-7836.2006.01758.x. J Thromb Haemost. 2006. PMID: 16420561 Free article.

4

An evaluation of cyclosporine alone for the treatment of early recurrences of thombotic thrombocytopenic purpura.

Cataland SR, Jin M, Zheng XL, George JN, Wu HM. Cataland SR, et al. J Thromb Haemost. 2006 May;4(5):1162-4. doi: 10.1111/j.1538-7836.2006.01909.x. J Thromb Haemost. 2006. PMID: 16689782 Free article. No abstract available.

5

Rapid determination of ADAMTS13 activity improves clinical decision-making.

Cataland SR, Jin M, Wu HM. Cataland SR, et al. Am J Hematol. 2007 Mar;82(3):251. doi: 10.1002/ajh.20746. Am J Hematol. 2007. PMID: 16929541 Free article. No abstract available.

6

Full evaluation of an acquired case of thrombotic thrombocytopenic purpura following the surgical resection of glioblastoma multiforme.

Cataland SR, Jin M, Smith E, Stanek M, Wu HM. Cataland SR, et al. J Thromb Haemost. 2006 Dec;4(12):2733-7. doi: 10.1111/j.1538-7836.2006.02217.x. Epub 2006 Sep 14. J Thromb Haemost. 2006. PMID: 16972936 Free article. No abstract available.

7

An evaluation of cyclosporin and corticosteroids individually as adjuncts to plasma exchange in the treatment of thrombotic thrombocytopenic purpura.

Cataland SR, Jin M, Ferketich AK, Kennedy MS, Kraut EH, George JN, Wu HM. Cataland SR, et al. Br J Haematol. 2007 Jan;136(1):146-9. doi: 10.1111/j.1365-2141.2006.06384.x. Epub 2006 Oct 27. Br J Haematol. 2007. PMID: 17069579 Free article. Clinical Trial.

8

Targeting the inhibitor of ADAMTS13 in thrombotic thrombocytopenic purpura.

Cataland SR, Wu HM. Cataland SR, et al. Expert Opin Pharmacother. 2007 Mar;8(4):437-44. doi: 10.1517/14656566.8.4.437. Expert Opin Pharmacother. 2007. PMID: 17309338 Review.

9

Cyclosporin and plasma exchange in thrombotic thrombocytopenic purpura: long-term follow-up with serial analysis of ADAMTS13 activity.

Cataland SR, Jin M, Lin S, Kennedy MS, Kraut EH, George JN, Wu HM. Cataland SR, et al. Br J Haematol. 2007 Nov;139(3):486-93. doi: 10.1111/j.1365-2141.2007.06819.x. Br J Haematol. 2007. PMID: 17910638 Free article.

10

Relationship between ADAMTS13 activity in clinical remission and the risk of TTP relapse.

Jin M, Casper TC, Cataland SR, Kennedy MS, Lin S, Li YJ, Wu HM. Jin M, et al. Among authors: cataland sr. Br J Haematol. 2008 May;141(5):651-8. doi: 10.1111/j.1365-2141.2008.07107.x. Epub 2008 Apr 7. Br J Haematol. 2008. PMID: 18397340 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

208 results

Search Page

Filters